Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Naproxen Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Naproxen Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Tablet
      • 1.3.3 Capsule
      • 1.3.4 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Naproxen Market Share by Application (2019-2025)
      • 1.4.2 Rheumatoid Arthritis
      • 1.4.3 Gout
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Naproxen Market Size
      • 2.1.1 Global Naproxen Revenue 2014-2025
      • 2.1.2 Global Naproxen Sales 2014-2025
    • 2.2 Naproxen Growth Rate by Regions
      • 2.2.1 Global Naproxen Sales by Regions 2014-2019
      • 2.2.2 Global Naproxen Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Naproxen Sales by Manufacturers
      • 3.1.1 Naproxen Sales by Manufacturers 2014-2019
      • 3.1.2 Naproxen Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Naproxen Revenue by Manufacturers (2014-2019)
      • 3.2.2 Naproxen Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Naproxen Market Concentration Ratio (CR5 and HHI)
    • 3.3 Naproxen Price by Manufacturers
    • 3.4 Key Manufacturers Naproxen Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Naproxen Market
    • 3.6 Key Manufacturers Naproxen Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Tablet Sales and Revenue (2014-2019)
      • 4.1.2 Capsule Sales and Revenue (2014-2019)
      • 4.1.3 Other Sales and Revenue (2014-2019)
    • 4.2 Global Naproxen Sales Market Share by Type
    • 4.3 Global Naproxen Revenue Market Share by Type
    • 4.4 Naproxen Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Naproxen Sales by Application

    6 United States

    • 6.1 United States Naproxen Breakdown Data by Company
    • 6.2 United States Naproxen Breakdown Data by Type
    • 6.3 United States Naproxen Breakdown Data by Application

    7 European Union

    • 7.1 European Union Naproxen Breakdown Data by Company
    • 7.2 European Union Naproxen Breakdown Data by Type
    • 7.3 European Union Naproxen Breakdown Data by Application

    8 China

    • 8.1 China Naproxen Breakdown Data by Company
    • 8.2 China Naproxen Breakdown Data by Type
    • 8.3 China Naproxen Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Naproxen Breakdown Data by Company
    • 9.2 Rest of World Naproxen Breakdown Data by Type
    • 9.3 Rest of World Naproxen Breakdown Data by Application
    • 9.4 Rest of World Naproxen Breakdown Data by Countries
      • 9.4.1 Rest of World Naproxen Sales by Countries
      • 9.4.2 Rest of World Naproxen Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Teva
      • 10.1.1 Teva Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Naproxen
      • 10.1.4 Naproxen Product Introduction
      • 10.1.5 Teva Recent Development
    • 10.2 Kirsch Pharma GmbH
      • 10.2.1 Kirsch Pharma GmbH Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Naproxen
      • 10.2.4 Naproxen Product Introduction
      • 10.2.5 Kirsch Pharma GmbH Recent Development
    • 10.3 Aurobindo
      • 10.3.1 Aurobindo Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Naproxen
      • 10.3.4 Naproxen Product Introduction
      • 10.3.5 Aurobindo Recent Development
    • 10.4 Divis Laboratories
      • 10.4.1 Divis Laboratories Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Naproxen
      • 10.4.4 Naproxen Product Introduction
      • 10.4.5 Divis Laboratories Recent Development
    • 10.5 Taj Pharmaceuticals Limited
      • 10.5.1 Taj Pharmaceuticals Limited Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Naproxen
      • 10.5.4 Naproxen Product Introduction
      • 10.5.5 Taj Pharmaceuticals Limited Recent Development
    • 10.6 Tianxin Pharmaceutical
      • 10.6.1 Tianxin Pharmaceutical Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Naproxen
      • 10.6.4 Naproxen Product Introduction
      • 10.6.5 Tianxin Pharmaceutical Recent Development
    • 10.7 Charioteer Pharmaceutical
      • 10.7.1 Charioteer Pharmaceutical Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Naproxen
      • 10.7.4 Naproxen Product Introduction
      • 10.7.5 Charioteer Pharmaceutical Recent Development
    • 10.8 Nhwa Pharmaceutical
      • 10.8.1 Nhwa Pharmaceutical Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Naproxen
      • 10.8.4 Naproxen Product Introduction
      • 10.8.5 Nhwa Pharmaceutical Recent Development
    • 10.9 Huazhong Pharma
      • 10.9.1 Huazhong Pharma Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Naproxen
      • 10.9.4 Naproxen Product Introduction
      • 10.9.5 Huazhong Pharma Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Naproxen Sales Channels
      • 11.2.2 Naproxen Distributors
    • 11.3 Naproxen Customers

    12 Market Forecast

    • 12.1 Global Naproxen Sales and Revenue Forecast 2019-2025
    • 12.2 Global Naproxen Sales Forecast by Type
    • 12.3 Global Naproxen Sales Forecast by Application
    • 12.4 Naproxen Forecast by Regions
      • 12.4.1 Global Naproxen Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Naproxen Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Naproxen is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Naproxen.

      This report studies the global market size of Naproxen, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Naproxen sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Teva
      Kirsch Pharma GmbH
      Aurobindo
      Divis Laboratories
      Taj Pharmaceuticals Limited
      Tianxin Pharmaceutical
      Charioteer Pharmaceutical
      Nhwa Pharmaceutical
      Huazhong Pharma

      Market Segment by Product Type
      Tablet
      Capsule
      Other

      Market Segment by Application
      Rheumatoid Arthritis
      Gout
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Naproxen status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Naproxen manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Naproxen are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now